Plasma adiponectin as a marker of insulin receptor dysfunction

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 977-979

  Semple, Robert K ^a,c   Cochran, Elaine K ^b   Soos, Maria A ^a   Burling, Keith A ^a   Savage, David B ^a   Gorden, Phillip ^b   O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; INSULIN; INSULIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; INSULIN RECEPTOROPATHY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; AMINO ACID SUBSTITUTION; BLOOD; GENETICS; MUTATION; OBESITY; PHYSIOLOGY;

ADIPONECTIN; AMINO ACID SUBSTITUTION; BIOLOGICAL MARKERS; HUMANS; INSULIN; INSULIN RESISTANCE; MUTATION; OBESITY; RECEPTOR, INSULIN;

EID: 48649092058     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2194     Document Type: Article

References (8)

1. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P: Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28- year perspective. Medicine (Baltimore) 81: 87-100, 2002
2. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P: Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine (Baltimore) 83:209-222, 2004
3. Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, Cochran EK, Dunger DB, Wareham NJ, Scherer PE, Gorden P, O'Rahilly S: Paradoxical elevation of high-molecular weight adiponec- tin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712-1717, 2007
4. Semple RK, Soos MA, LuanJ, Mitchell CS, Gurnell M, Cochran EK, Gorden P, Chat- terjee VK, Wareham NJ, O'Rahilly S: Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219-3223, 2006
5. Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ: Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone- binding globulin and body fat. Diabetes Care 27:861-868, 2004
6. Maddux BA, Chan A, De Filippis EA, Mandarino LJ, Goldfine ID: IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 29:1535-1537, 2006
7. Coll AP, Morganstein D, Jayne D, Soos MA, O'Rahilly S, Burke J: Successful treatment of type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus. Diabet Med 22: 814-815, 2005
8. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME: Enzyme immuno- assay for intact human insulin in serum or plasma. Clin Chem 39:578-582, 1993